+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

North America Fluorescent Immunoassay Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type, Application, and End User

  • PDF Icon

    Report

  • 153 Pages
  • August 2022
  • Region: North America
  • The Insight Partners
  • ID: 5647346
UP TO OFF until Mar 31st 2024
The North America fluorescent immunoassay market is expected to grow from US$ 1,072.41 million in 2021 to US$ 1,598.58 million by 2028; it is estimated to register a CAGR of 5.9% from 2021 to 2028.

Fluorescent immunoassays are diagnostic tools for quality control and the quantity-specific detection of antigens and antibodies. The technique derives from the fundamental immunological concept of antigen-antibody binding. These are used in screening to quantify the production or inhibition of antigens/haptens associated with a disease target. These antigens or haptens are characteristic of the disease process and are mediated by the target, such as cytokines or growth factors. Cell therapy is the practice of using cellular material to produce the desired effect in vitro or in vivo through their biological activities and properties. The cells used for the treatments can be classified as either allogeneic or autologous. Modern cell-based therapies also include regenerating human cells, tissue, or organs. The basis of the cells used comes from the stem and progenitor cells, mature and functionally differentiated cells, or artificially produced tissue. Fluorescence-activated cell sorting (FACS) is a highly flexible technique with many options for stem cell sorting. It is also the only way to isolate a particular stem cell population using multiple internal and external markers. FACS is a specialized type of flow cytometry that sorts a heterogeneous mixture of cells based on each cell's specific light scatter and fluorescence properties. Cells are first tagged with fluorescent antibodies that bind to relevant proteins on target cells. Single cells pass a laser beam, and a detector measures fluorescence, forward scattered light (FSC), and side spread light (SSC). FSC and SSC are used to determine the size of the cell. Fluorescence at multiple wavelengths can be detected simultaneously but depends on the instrument's specific lasers, filters, and detectors. The cells are then physically sorted into different bins based on captured measurements and user-entered parameters. Fluorescence-activated cell sorting allows for current and future need for cell isolation to conduct efficient stem cell research. Thus, there is a growing demand for fluorescent immunoassays for providing quality and quantity-specific detection of antigens and antibodies.

With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America fluorescent immunoassay market at a notable CAGR during the forecast period.

North America Fluorescent Immunoassay Market Segmentation

The North America fluorescent immunoassay market is segmented into product type, application, end user, and country. Based on product type, the market is segmented into ELISA, rapid lateral flow immunoassay, and others. The ELISA segment dominated the market in 2021 and is expected to register the highest CAGR during the forecast period. Based on application, the market is segmented into infectious diseases, oncology, cardiovascular diseases, and others. The infectious disease segment dominated the market in 2021 and is expected to register the highest CAGR during the forecast period. Based on end user, the market is segmented into hospitals & clinics, diagnostic centers, pharmaceutical & biotechnology companies, academic & research institutes, and others. The hospitals and clinics segment dominated the market in 2021 and is expected to register the highest CAGR during the forecast period. Based on country, the North America fluorescent immunoassay market is segmented into the US, Canada, and Mexico.

Abbott, BD, bioMerieux SA, Danaher, F. Hoffmann-La Roche Ltd., Ortho Clinical Diagnostics Holdings plc, Quidel Corporation, Siemens AG, Sysmex Corporation, and Thermo Fisher Scientific Inc. are among the leading companies operating in the North America fluorescent immunoassay market.
Frequently Asked Questions about the North American Fluorescent Immunoassay Market

What is the estimated value of the North American Fluorescent Immunoassay Market?

The North American Fluorescent Immunoassay Market was estimated to be valued at $1072.41 Million in 2022.

What is the growth rate of the North American Fluorescent Immunoassay Market?

The growth rate of the North American Fluorescent Immunoassay Market is 5.9%, with an estimated value of $1598.58 Million by 2028.

What is the forecasted size of the North American Fluorescent Immunoassay Market?

The North American Fluorescent Immunoassay Market is estimated to be worth $1598.58 Million by 2028.

Who are the key companies in the North American Fluorescent Immunoassay Market?

Key companies in the North American Fluorescent Immunoassay Market include Abbott, BD, bioMerieux SA, Danaher, F. Hoffmann, La Roche Ltd., Ortho Clinical Diagnostics Holdings plc, Quidel Corporation, Siemens AG and Sysmex Corporation.

Table of Contents

1. Introduction
1.1 Study Scope
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Fluorescent Immunoassay Market - By Product Type
1.3.2 North America Fluorescent Immunoassay Market - By Application
1.3.3 North America Fluorescent Immunoassay Market - By End User
1.3.4 North America Fluorescent Immunoassay Market - By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Fluorescent Immunoassay Market - Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Expert Opinions
5. North America Fluorescent Immunoassay Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Prevalence of Chronic Diseases
5.1.2 Increasing Demand for Cell Therapies
5.2 Market Restraints
5.2.1 Disadvantages of Fluorescent Immunoassays
5.3 Market Opportunities
5.3.1 Extensive Usage in Cancer Diagnostics
5.4 Future Trends
5.4.1 Increase in Development of Fluorescent Dyes and Instruments
5.5 Impact Analysis
6. Fluorescent Immunoassay Market - North America Analysis
6.1 North America Fluorescent Immunoassay Marker Revenue Forecast and Analysis
7. North America Fluorescent Immunoassay Market Analysis - By Product Type
7.1 Overview
7.2 North America Fluorescent Immunoassay Market Share by Product Type - 2021 & 2028 (%)
7.3 ELISA
7.3.1 Overview
7.3.2 ELISA: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
7.4 Rapid Lateral Flow Immunoassay
7.4.1 Overview
7.4.2 Rapid Lateral Flow Immunoassay: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
8. North America Fluorescent Immunoassay Market Analysis - By Application
8.1 Overview
8.2 North America Fluorescent Immunoassay Market Share by Application - 2021 & 2028 (%)
8.3 Infectious Diseases
8.3.1 Overview
8.3.2 Infectious Diseases: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
8.4 Oncology
8.4.1 Overview
8.4.2 Oncology: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
8.5 Cardiovascular Disease
8.5.1 Overview
8.5.2 Cardiovascular Disease: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
9. North America Fluorescent Immunoassay Market Analysis - By End User
9.1 Overview
9.2 North America Fluorescent Immunoassay Market Share by End User - 2021 & 2028 (%)
9.3 Hospitals & Clinics
9.3.1 Overview
9.3.2 Hospitals & Clinics: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
9.4 Diagnostic Centers
9.4.1 Overview
9.4.2 Diagnostic Centers: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
9.5 Pharmaceutical & Biotechnology Companies
9.5.1 Overview
9.5.2 Pharmaceutical & Biotechnology Companies: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
9.6 Academic & Research Institutes
9.6.1 Overview
9.6.2 Academic & Research Institutes: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
9.7 Others
9.7.1 Overview
9.7.2 Others: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
10. North America Fluorescent Immunoassay Market Analysis - By Country
10.1 Overview
10.1.1 North America Fluorescent Immunoassay Market Revenue and Forecasts to 2028, By Country (%)
10.1.1.1 US: Fluorescent Immunoassay Market - Revenue and Forecast to 2028 (USD million)
10.1.1.1.1 Overview
10.1.1.1.2 US: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
10.1.1.1.3 US: Fluorescent Immunoassay Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
10.1.1.1.4 US: Fluorescent Immunoassay Market, by Application - Revenue and Forecast to 2028 (USD Million)
10.1.1.1.5 US: Fluorescent Immunoassay Market, by End User - Revenue and Forecast to 2028 (USD Million)
10.1.1.2 Canada: Fluorescent Immunoassay Market - Revenue and Forecast to 2028 (USD million)
10.1.1.2.1 Overview
10.1.1.2.2 Canada: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
10.1.1.2.3 Canada: Fluorescent Immunoassay Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
10.1.1.2.4 Canada: Fluorescent Immunoassay Market, by Application - Revenue and Forecast to 2028 (USD Million)
10.1.1.2.5 Canada: Fluorescent Immunoassay Market, by End User - Revenue and Forecast to 2028 (USD Million)
10.1.1.3 Mexico: Fluorescent Immunoassay Market - Revenue and Forecast to 2028 (USD Million)
10.1.1.3.1 Overview
10.1.1.3.2 Mexico: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
10.1.1.3.3 Mexico: Fluorescent Immunoassay Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
10.1.1.3.4 Mexico: Fluorescent Immunoassay Market, by Application - Revenue and Forecast to 2028 (USD Million)
10.1.1.3.5 Mexico: Fluorescent Immunoassay Market, by End User - Revenue and Forecast to 2028 (USD Million)
11. Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Company Profiles
12.1 F. Hoffmann-La Roche Ltd.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Thermo Fisher Scientific Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Abbott
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 BD
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Danaher
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 bioMerieux SA
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Sysmex Corporation
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Siemens AG
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Ortho Clinical Diagnostics Holdings plc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Quidel Corporation
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About the Publisher
13.2 Glossary of Terms
List of Figures
Figure 1. North America Fluorescent Immunoassay Market Segmentation
Figure 2. North America Fluorescent Immunoassay Market - By Country
Figure 3. North America Fluorescent Immunoassay Market Overview
Figure 4. North America Fluorescent Immunoassay Market, By Product Type
Figure 5. North America Fluorescent Immunoassay Market, By Country
Figure 6. North America PEST Analysis
Figure 7. North America Fluorescent Immunoassay Market Impact Analysis of Driver and Restraints
Figure 8. North America Fluorescent Immunoassay Market - Revenue Forecast and Analysis
Figure 9. North America Fluorescent Immunoassay Market Share by Product Type - 2021 & 2028 (%)
Figure 10. North America ELISA: Fluorescent Immunoassay Market Revenue and Forecasts To 2028 (USD Million)
Figure 11. North America Rapid Lateral Flow Immunoassay: Fluorescent Immunoassay Market Revenue and Forecasts To 2028 (USD Million)
Figure 12. North America Others: Fluorescent Immunoassay Market Revenue and Forecasts To 2028 (USD Million)
Figure 13. North America Fluorescent Immunoassay Market Share by Application - 2021 & 2028 (%)
Figure 14. North America Infectious Diseases: Fluorescent Immunoassay Market Revenue and Forecasts To 2028 (USD Million)
Figure 15. North America Oncology: Fluorescent Immunoassay Market Revenue and Forecasts To 2028 (USD Million)
Figure 16. North America Cardiovascular Disease: Fluorescent Immunoassay Market Revenue and Forecasts To 2028 (USD Million)
Figure 17. North America Others: Fluorescent Immunoassay Market Revenue and Forecasts To 2028 (USD Million)
Figure 18. North America Fluorescent Immunoassay Market Share by End User - 2021 & 2028 (%)
Figure 19. North America Hospitals & Clinics: Fluorescent Immunoassay Market Revenue and Forecasts To 2028 (USD Million)
Figure 20. North America Diagnostic Centers: Fluorescent Immunoassay Market Revenue and Forecasts To 2028 (USD Million)
Figure 21. North America Pharmaceutical & Biotechnology Companies: Fluorescent Immunoassay Market Revenue and Forecasts To 2028 (USD Million)
Figure 22. North America Academic & Research Institutes: Fluorescent Immunoassay Market Revenue and Forecasts To 2028 (USD Million)
Figure 23. North America Others: Fluorescent Immunoassay Market Revenue and Forecasts To 2028 (USD Million)
Figure 24. North America Fluorescent Immunoassay Market Revenue Overview, by Country, 2021 (US$ Million)
Figure 25. North America Fluorescent Immunoassay Market Revenue and Forecasts to 2028, By Country (%)
Figure 26. US: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
Figure 27. Canada: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
Figure 28. Mexico: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
List of Tables
Table 1. North America Fluorescent Immunoassay Market -Revenue and Forecast to 2028 (USD Million)
Table 2. US: Fluorescent Immunoassay Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
Table 3. US: Fluorescent Immunoassay Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 4. US: Fluorescent Immunoassay Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 5. Canada: Fluorescent Immunoassay Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
Table 6. Canada: Fluorescent Immunoassay Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 7. Canada: Fluorescent Immunoassay Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 8. Mexico: Fluorescent Immunoassay Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
Table 9. Mexico: Fluorescent Immunoassay Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 10. Mexico: Fluorescent Immunoassay Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 11. Organic Developments
Table 12. Inorganic Developments
Table 13. Glossary of Terms

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott
  • BD
  • bioMerieux SA
  • Danaher
  • F. Hoffmann-La Roche Ltd.
  • Ortho Clinical Diagnostics Holdings plc
  • Quidel Corporation
  • Siemens AG
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.